Molecular epidemiology of a Malassezia pachydermatis neonatal unit outbreak

Medical Mycology

Volumn 56, Issue 1, 2018, Pages 69-77

  Ilahi, Amin ^a   Hadrich, Inès ^a   Goudjil, Sabrina ^b   Kongolo, Guy ^b   Chazal, Christèle ^b   Léké, André ^b   Ayadi, Ali ^a   Chouaki, Taieb ^b   Ranque, Stéphane ^c,d  

^a UNIVERSITY OF SFAX   (Tunisia)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c Aix Marseilles University   (France)

^d TIMONE HOSPITAL   (France)

Author keywords

IGS1; Malassezia pachydermatis; Neonates; Outbreak; Typing

Indexed keywords

FLUCONAZOLE; LIPID; SPACER DNA; FUNGAL DNA; RIBOSOMAL SPACER DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; FEMALE; FUNGAL COLONIZATION; FUNGUS ISOLATION; GENETIC POLYMORPHISM; GENOTYPE; HAND WASHING; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MALASSEZIA PACHYDERMATIS; MALASSEZIA PACHYDERMATIS INFECTION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; SEQUENCE ALIGNMENT; ADULT; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; CROSS INFECTION; DERMATOMYCOSIS; DNA SEQUENCE; FRANCE; GENETICS; INFANT; ISOLATION AND PURIFICATION; MALASSEZIA; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MICROBIOLOGY; NEONATAL INTENSIVE CARE UNIT; PHYLOGENY; PROCEDURES; UNIVERSITY HOSPITAL;

ADULT; CLUSTER ANALYSIS; CROSS INFECTION; DERMATOMYCOSES; DISEASE OUTBREAKS; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; FEMALE; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE UNITS, NEONATAL; MALASSEZIA; MALE; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 85028612188     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1093/mmy/myx022     Document Type: Article

References (33)

1. Negre A, Bensignor E, Guillot J. Evidence-based veterinary dermatology: a systematic review of interventions for Malassezia dermatitis in dogs. Vet Dermatol. 2009; 20: 1–12.
2. Velegraki A, Cafarchia C, Gaitanis G et al. Malassezia infections in humans and animals: pathophysiology, detection, and treatment. PLoS pathog. 2015; 11: e1004523.
3. Prohic A, Kasumagic-Halilovic E. Identification of Malassezia species from immunocompetent and immunocompromised patients with seborrheic dermatitis. Eur Revr Med Pharmacol Sci. 2010; 14: 1019–1023.
4. Welbel SF, McNeil MM, Pramanik A et al. Nosocomial Malassezia pachydermatis bloodstream infections in a neonatal intensive care unit. Pediatr Infect Dis J. 1994; 13: 104–108.
5. Larocco M, Dorenbaum A, Robinson A et al. Recovery of Malassezia pachydermatis from eight infants in a neonatal intensive care nursery: clinical and laboratory features. Pediatr Infect Dis J. 1988; 7: 398–401.
6. Hadrich I, Ranque S. Typing of fungi in an outbreak setting: lessons learned. Curr Fungal Infect Rep. 2015; 9: 314–323.
7. Guillot J, Gueho E, Chevrier G et al. Epidemiological analysis of Malassezia pachydermatis isolates by partial sequencing of the large subunit ribosomal RNA. Res Vet Sci. 1997; 62: 22–25.
8. Aizawa T, Kano R, Nakamura Y et al. The genetic diversity of clinical isolates of Malassezia pachydermatis from dogs and cats. Med Mycol. 2001; 39: 329–334.
9. Sugita T, Takeo K, Hama K et al. DNA sequence diversity of intergenic spacer I region in the non-lipid-dependent species Malassezia pachydermatis isolated from animals. Med Mycol. 2005; 43: 21–26.
10. Mickelsen PA, Viano-Paulson MC, Stevens DA et al. Clinical and microbiological features of infection with Malassezia pachydermatis in high-risk infants. J Infect Dis. 1988; 157: 1163–1168.
11. Bond R, Anthony RM. Characterization of markedly lipid-dependent Malassezia pachydermatis isolates from healthy dogs. J Appl Bacteriol. 1995; 78: 537–542.
12. Cassagne C, Cella AL, Suchon P et al. Evaluation of four pretreatment procedures for MALDI-TOF MS yeast identification in the routine clinical laboratory. Med Mycol. 2013; 51: 371–377.
13. Sugita T, Kodama M, Saito M et al. Sequence diversity of the intergenic spacer region of the rRNA gene of Malassezia globosa colonizing the skin of patients with atopic dermatitis and healthy individuals. J Clin Microbiol. 2003; 41: 3022–3027.
14. Tamura K, Stecher G, Peterson D et al. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013; 30: 2725–2729.
15. Huson DH, Bryant D. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol. 2006; 23: 254–267.
16. Figueredo LA, Cafarchia C, Otranto D. Antifungal susceptibility of Malassezia pachydermatis biofilm. Med Mycol. 2013; 51: 863–867.
17. Kaur M, Narang T, Bala M et al. Study of the distribution of Malassezia species in patients with pityriasis versicolor and healthy individuals in Tertiary Care Hospital, Punjab. Indian J Med Microbiol. 2013; 31: 270–274.
18. Devlin RK. Invasive fungal infections caused by Candida and Malassezia species in the neonatal intensive care unit. Adv Neonatal Care. 2006; 6: 68–77.
19. Cafarchia C, Otranto D. The pathogenesis of Malassezia yeasts. Parassi-tologia. 2008; 50: 65–67.
20. Ashbee HR, Evans EG. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev. 2002; 15: 21–57.
21. Gueho E, Simmons RB, Pruitt WR et al. Association of Malassezia pachydermatis with systemic infections of humans. J Clin Microbiol. 1987; 25: 1789–1790.
22. Lautenbach E, Nachamkin I, Schuster MG. Malassezia pachydermatis infections. N Engl J Med. 1998; 339: 270; author reply 271.
23. Iatta R, Cafarchia C, Cuna T et al. Bloodstream infections by Malassezia and Candida species in critical care patients. Med Mycol. 2014; 52: 264–269.
24. Chryssanthou E, Broberger U, Petrini B. Malassezia pachydermatis fun-gaemia in a neonatal intensive care unit. Acta Paediatr. 2001; 90: 323–327.
25. van Belkum A, Boekhout T, Bosboom R. Monitoring spread of Malassezia infections in a neonatal intensive care unit by PCR-mediated genetic typing. J Clin Microbiol. 1994; 32: 2528–2532.
26. Nagata R, Nagano H, Ogishima D et al. Transmission of the major skin microbiota, Malassezia, from mother to neonate. Pediatr Int. 2012; 54: 350–355.
27. Chang HJ, Miller HL, Watkins N et al. An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers’ pet dogs. N Engl J Med. 1998; 338: 706–711.
28. Al-Sweih N, Ahmad S, Joseph L et al. Malassezia pachydermatis fungemia in a preterm neonate resistant to fluconazole and flucytosine. Med Mycology Case Rep. 2014; 5: 9–11.
29. Kolecka A, Khayhan K, Arabatzis M et al. Efficient identification of Malassezia yeasts by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Brit J Dermatol. 2014; 170: 332–341.
30. Yamamoto M, Umeda Y, Yo A et al. Utilization of matrix-assisted laser desorption and ionization time-of-flight mass spectrometry for identification of infantile seborrheic dermatitis-causing Malassezia and incidence of culture-based cutaneous Malassezia microbiota of 1-month-old infants. J Dermatol. 2014; 41: 117–123.
31. Kobayashi T, Kano R, Nagata M et al. Genotyping of Malassezia pachydermatis isolates from canine healthy skin and atopic dermatitis by internal spacer 1 (IGS1) region analysis. Vet Dermatol. 2011; 22: 401–405.
32. Gaitanis G, Magiatis P, Hantschke M et al. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012; 25: 106–141.
33. Koike A, Kano R, Nagata M et al. Genotyping of Malassezia pachydermatis isolates from canine healthy skin and lesional skin of atopic dermatitis in Japan, Korea and Taiwan. J Vet Med Sci. 2013; 75: 955–958.